pneumonia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Those who meet the criteria for Western medicine diagnosis and traditional Chinese medicine differentiation in CAP; (2) Age range from 1 to 14 years old; (3) Agree to cooperate with medication and undergo evaluation according to the requirements of the experimental protocol; (4) The informed consent of the legal guardian of the subject must be obtained and a voluntary informed consent form must be signed; When participants are able to make decisions to participate in clinical trials their consent must also be obtained.
Exclusion criteria
Exclusion criteria: (1) Individuals who are allergic to the experimental drug or its formulation ingredients or have an allergic constitution; (2) Complications of combined pneumonia (empyema pneumothorax pulmonary bullae etc.) severe pneumonia; (3) Merge severe primary diseases such as heart liver kidney digestive and hematopoietic systems as well as psychiatric patients; (4) Individuals who have participated in clinical trials within the past three months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cough Visual Analog Scale (VAS) score;Time window for the efficacy of pediatric pneumonia;The total response rate of the disease; | — |
Secondary
| Measure | Time frame |
|---|---|
| Individual symptoms and pulmonary signs;Medication compliance;Comparison of blood routine and C-reactive protein levels;Patient Efficacy Satisfaction Questionnaire (ESQ);Improvement in quality of life rating( EQ-5D );TCM syndrome effect;Conversion rate; | — |
Countries
China
Contacts
The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine